Current Progress on the Genomics of Schistosomiasis for Drug Discovery and Diagnostics

Nileshkumar       Meghani; Beom-Jin       Lee; Hardik       Amin; Behzad       Nili-Ahmadabadi; Saraswathy       Nagendran
Abstract

For a number of decades, schistosomiasis has remained a public threat and an economic burden in a number of countries, directly impacting over 200 million people. The past 15 years have seen tremendous progress in the development of high-throughput methods for targeting or compound selection that are vital to early-stage schistosome drug discovery research. Genomewide approaches to analyze gene expression at the transcriptional and other -omic levels have helped immensely for gaining insight into the pathways and mechanisms involved in the schistosomiasis and it is expected to revolutionize the drug discovery as well as related diagnostics. This review discusses the most recent progress of pharmacology and genomics concerning schistosomiasis with a focus on drug discovery and diagnostic tools. It also provides chemical structural insights of promising targets along with available in vitro and/or in vivo data. Although significant research has been done to identify new molecules for the treatment and new methods for diagnosis, the necessity of new options for the sustainable control of schistosomiasis remains a great challenge.
Keywords: Genomics, drug discovery, personalized medicine, schistosomiasis vaccine, praziquantel, pharmacology.
[1] 
Naghavi, M.; Abajobir, A.A.; Abbafati, C.; Abbas, K.M.; Abd-Allah, F.; Abera, S.F.; Aboyans, V.; Adetokunboh, O.; Afshin, A.; Agrawal, A. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet,  2017, 390(10100), 1151-1210.
[http://dx.doi.org/10.1016/S0140-6736(17)32152-9] [PMID: 28919116] 
[2] 
Mäder, P.; Rennar, G.A.; Ventura, A.M.P.; Grevelding, C.G.; Schlitzer, M. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future. ChemMedChem,  2018, 13(22), 2374-2389.
[http://dx.doi.org/10.1002/cmdc.201800572] [PMID: 30212614] 
[3] 
Clerinx, J.; Van Gompel, A. Schistosomiasis in travellers and migrants. Travel Med. Infect. Dis.,  2011, 9(1), 6-24.
[http://dx.doi.org/10.1016/j.tmaid.2010.11.002] [PMID: 21216199] 
[4] 
Bergquist, N.R. Schistosomiasis: from risk assessment to control. Trends Parasitol.,  2002, 18(7), 309-314.
[http://dx.doi.org/10.1016/S1471-4922(02)02301-2] [PMID: 12379951] 
[5] 
Elbaz, T.; Esmat, G. Hepatic and intestinal schistosomiasis. review. J. Adv. Res.,  2013, 4(5), 445-452.
[http://dx.doi.org/10.1016/j.jare.2012.12.001] [PMID: 25685451] 
[6] 
Hibberd, M.L. Microbial genomics: an increasingly revealing interface in human health and disease. Genome Med.,  2013, 5(4), 31-31.
[http://dx.doi.org/10.1186/gm435] [PMID: 23673079] 
[7] 
Relman, D.A.; Guttmacher, A.E.; Relman, D.A. Microbial genomics and infectious diseases. N. Engl. J. Med.,  2011, 365(4), 347-357.
[http://dx.doi.org/10.1056/NEJMra1003071] [PMID: 21793746] 
[8] 
Oliveira, G.; Pierce, R.J. How has the genomics era impacted schistosomiasis drug discovery? Future Med. Chem.,  2015, 7(6), 685-687.
[http://dx.doi.org/10.4155/fmc.15.30] [PMID: 25996060] 
[9] 
Valentim, C.L.; Cioli, D.; Chevalier, F.D.; Cao, X.; Taylor, A.B.; Holloway, S.P.; Pica-Mattoccia, L.; Guidi, A.; Basso, A.; Tsai, I.J.; Berriman, M.; Carvalho-Queiroz, C.; Almeida, M.; Aguilar, H.; Frantz, D.E.; Hart, P.J.; LoVerde, P.T.; Anderson, T.J. Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites. Science,  2013, 342(6164), 1385-1389.
[http://dx.doi.org/10.1126/science.1243106] [PMID: 24263136] 
[10] 
Berriman, M.; Haas, B.J.; LoVerde, P.T.; Wilson, R.A.; Dillon, G.P.; Cerqueira, G.C.; Mashiyama, S.T.; Al-Lazikani, B.; Andrade, L.F.; Ashton, P.D.; Aslett, M.A.; Bartholomeu, D.C.; Blandin, G.; Caffrey, C.R.; Coghlan, A.; Coulson, R.; Day, T.A.; Delcher, A.; DeMarco, R.; Djikeng, A.; Eyre, T.; Gamble, J.A.; Ghedin, E.; Gu, Y.; Hertz-Fowler, C.; Hirai, H.; Hirai, Y.; Houston, R.; Ivens, A.; Johnston, D.A.; Lacerda, D.; Macedo, C.D.; McVeigh, P.; Ning, Z.; Oliveira, G.; Overington, J.P.; Parkhill, J.; Pertea, M.; Pierce, R.J.; Protasio, A.V.; Quail, M.A.; Rajandream, M.A.; Rogers, J.; Sajid, M.; Salzberg, S.L.; Stanke, M.; Tivey, A.R.; White, O.; Williams, D.L.; Wortman, J.; Wu, W.; Zamanian, M.; Zerlotini, A.; Fraser-Liggett, C.M.; Barrell, B.G.; El-Sayed, N.M. The genome of the blood fluke Schistosoma mansoni. Nature,  2009, 460(7253), 352-358.
[http://dx.doi.org/10.1038/nature08160] [PMID: 19606141] 
[11] 
Zhou, Y.; Zheng, H.; Chen, X.; Zhang, L.; Wang, K.; Guo, J.; Huang, Z.; Zhang, B.; Huang, W.; Jin, K. Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature,  2009, 460(7253), 345-351.
[http://dx.doi.org/10.1038/nature08140] [PMID: 19606140] 
[12] 
Kasinathan, R.S.; Greenberg, R.M. Pharmacology and potential physiological significance of schistosome multidrug resistance transporters. Exp. Parasitol.,  2012, 132(1), 2-6.
[http://dx.doi.org/10.1016/j.exppara.2011.03.004] [PMID: 21420955] 
[13] 
James, C.E.; Hudson, A.L.; Davey, M.W. An update on P-glycoprotein and drug resistance in Schistosoma mansoni. Trends Parasitol.,  2009, 25(12), 538-539.
[http://dx.doi.org/10.1016/j.pt.2009.09.007] [PMID: 19850522] 
[14] 
Lespine, A.; Alvinerie, M.; Vercruysse, J.; Prichard, R.K.; Geldhof, P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol.,  2008, 24(7), 293-298.
[http://dx.doi.org/10.1016/j.pt.2008.03.011] [PMID: 18514030] 
[15] 
Zutz, A.; Gompf, S.; Schägger, H.; Tampé, R. Mitochondrial ABC proteins in health and disease. Biochim. Biophys. Acta,  2009, 1787(6), 681-690.
[http://dx.doi.org/10.1016/j.bbabio.2009.02.009] [PMID: 19248758] 
[16] 
Kasinathan, R.S.; Morgan, W.M.; Greenberg, R.M. Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel. Mol. Biochem. Parasitol.,  2010, 173(1), 25-31.
[http://dx.doi.org/10.1016/j.molbiopara.2010.05.003] [PMID: 20470831] 
[17] 
Kasinathan, R.S.; Goronga, T.; Messerli, S.M.; Webb, T.R.; Greenberg, R.M. Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel. FASEB J.,  2010, 24(1), 128-135.
[http://dx.doi.org/10.1096/fj.09-137091] [PMID: 19726755] 
[18] 
Greenberg, R.M. Schistosome ABC multidrug transporters: From pharmacology to physiology. Int. J. Parasitol. Drugs Drug Resist.,  2014, 4(3), 301-309.
[http://dx.doi.org/10.1016/j.ijpddr.2014.09.007] [PMID: 25516841] 
[19] 
MacDonald, K.; Kimber, M.J.; Day, T.A.; Ribeiro, P. A constitutively active G protein-coupled acetylcholine receptor regulates motility of larval Schistosoma mansoni. Mol. Biochem. Parasitol.,  2015, 202(1), 29-37.
[http://dx.doi.org/10.1016/j.molbiopara.2015.09.001] [PMID: 26365538] 
[20] 
Patocka, N.; Sharma, N.; Rashid, M.; Ribeiro, P. Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement. PLoS Pathog.,  2014, 10(1)e1003878
[http://dx.doi.org/10.1371/journal.ppat.1003878] [PMID: 24453972] 
[21] 
Chan, J.D.; McCorvy, J.D.; Acharya, S.; Johns, M.E.; Day, T.A.; Roth, B.L.; Marchant, J.S. A Miniaturized Screen of a Schistosoma mansoni Serotonergic G Protein-Coupled Receptor Identifies Novel Classes of Parasite-Selective Inhibitors. PLoS Pathog.,  2016, 12(5)e1005651
[http://dx.doi.org/10.1371/journal.ppat.1005651] [PMID: 27187180] 
[22] 
Chan, J.D.; Acharya, S.; Day, T.A.; Marchant, J.S. Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist. Int. J. Parasitol. Drugs Drug Resist.,  2016, 6(3), 364-370.
[http://dx.doi.org/10.1016/j.ijpddr.2016.06.001] [PMID: 27397763] 
[23] 
Bais, S.; Churgin, M.A.; Fang-Yen, C.; Greenberg, R.M. Evidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoni. PLoS Negl. Trop. Dis.,  2015, 9(12)e0004295
[http://dx.doi.org/10.1371/journal.pntd.0004295] [PMID: 26655809] 
[24] 
Greenberg, R.M. Ion channels and drug transporters as targets for anthelmintics. Curr. Clin. Microbiol. Rep.,  2014, 1(3-4), 51-60.
[http://dx.doi.org/10.1007/s40588-014-0007-6] [PMID: 25554739] 
[25] 
Wolstenholme, A.J. Ion channels and receptor as targets for the control of parasitic nematodes. Int. J. Parasitol. Drugs Drug Resist.,  2011, 1(1), 2-13.
[http://dx.doi.org/10.1016/j.ijpddr.2011.09.003] [PMID: 24533259] 
[26] 
Bais, S.; Berry, C.T.; Liu, X.; Ruthel, G.; Freedman, B.D.; Greenberg, R.M. Atypical pharmacology of schistosome TRPA1-like ion channels. PLoS Negl. Trop. Dis.,  2018, 12(5)e0006495
[http://dx.doi.org/10.1371/journal.pntd.0006495] [PMID: 29746471] 
[27] 
Bakkali, N.; Fenollar, F.; Biswas, S.; Rolain, J-M.; Raoult, D. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene. J. Infect. Dis.,  2008, 198(1), 101-108.
[http://dx.doi.org/10.1086/588706] [PMID: 18500934] 
[28] 
Cowman, A.F.; Crabb, B.S. Functional genomics: identifying drug targets for parasitic diseases. Trends Parasitol.,  2003, 19(11), 538-543.
[http://dx.doi.org/10.1016/j.pt.2003.09.006] [PMID: 14580967] 
[29] 
Foster, J.M.; Johnston, D.A. Helminth genomics: from gene discovery to genome sequencing. Trends Parasitol.,  2002, 18(6), 241-242.
[http://dx.doi.org/10.1016/S1471-4922(02)02284-5] [PMID: 12036729] 
[30] 
Strausberg, R.L.; Schreiber, S.L. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science,  2003, 300(5617), 294-295.
[http://dx.doi.org/10.1126/science.1083395] [PMID: 12690189] 
[31] 
Greenbaum, D.C.; Baruch, A.; Grainger, M.; Bozdech, Z.; Medzihradszky, K.F.; Engel, J.; DeRisi, J.; Holder, A.A.; Bogyo, M. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science,  2002, 298(5600), 2002-2006.
[http://dx.doi.org/10.1126/science.1077426] [PMID: 12471262] 
[32] 
Melman, S.D.; Steinauer, M.L.; Cunningham, C.; Kubatko, L.S.; Mwangi, I.N.; Wynn, N.B.; Mutuku, M.W.; Karanja, D.M.; Colley, D.G.; Black, C.L.; Secor, W.E.; Mkoji, G.M.; Loker, E.S. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl. Trop. Dis.,  2009, 3(8)e504
[http://dx.doi.org/10.1371/journal.pntd.0000504] [PMID: 19688043] 
[33] 
Smits, H.L. Prospects for the control of neglected tropical diseases by mass drug administration. Expert Rev. Anti Infect. Ther.,  2009, 7(1), 37-56.
[http://dx.doi.org/10.1586/14787210.7.1.37] [PMID: 19622056] 
[34] 
Danso-Appiah, A.; Olliaro, P.L.; Donegan, S.; Sinclair, D.; Utzinger, J. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst. Rev., 2013, (2)CD000528
[PMID: 23450530] 
[35] 
Kramer, C.V.; Zhang, F.; Sinclair, D.; Olliaro, P.L. Drugs for treating urinary schistosomiasis. Cochrane Libr., 2014.
[http://dx.doi.org/10.1002/14651858.CD000053.pub3] 
[36] 
Rugel, A.; Taylor, A.B.; Cao, X.; Hart, P.J.; McHardy, S.F.; Tarpley, R.; Chevalier, F.; Anderson, T.J.; LoVerde, P.T. Why does oxamniquine kill schistosoma mansoni but not S. haematobium or S. japonicum?; AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, AMER SOC TROP MED & HYGIENE, 2017, pp. 32-33.
[37] 
Hess, J.; Panic, G.; Patra, M.; Mastrobuoni, L.; Spingler, B.; Roy, S.; Keiser, J.; Gasser, G. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium. ACS Infect. Dis.,  2017, 3(9), 645-652.
[http://dx.doi.org/10.1021/acsinfecdis.7b00054] [PMID: 28686009] 
[38] 
Badria, F.; Abou-Mohamed, G.; El-Mowafy, A.; Masoud, A.; Salama, O. Mirazid: a new schistosomicidal drug. Pharm. Biol.,  2001, 39(2), 127-131.
[http://dx.doi.org/10.1076/phbi.39.2.127.6253] 
[39] 
Tonkal, A.M.; Morsy, T.A. An update review on Commiphora molmol and related species. J. Egypt. Soc. Parasitol.,  2008, 38(3), 763-796.
[PMID: 19209761] 
[40] 
Ramaswamy, K.; He, Y-X.; Salafsky, B.; Shibuya, T. Topical application of DEET for schistosomiasis. Trends Parasitol.,  2003, 19(12), 551-555.
[http://dx.doi.org/10.1016/j.pt.2003.10.001] [PMID: 14642762] 
[41] 
el Kouni, M.H. Potential chemotherapeutic targets in the purine metabolism of parasites. Pharmacol. Ther.,  2003, 99(3), 283-309.
[http://dx.doi.org/10.1016/S0163-7258(03)00071-8] [PMID: 12951162] 
[42] 
Pereira, H.M.; Cleasby, A.; Pena, S.S.D.; Franco, G.G.R.; Garratt, R.C. Cloning, expression and preliminary crystallographic studies of the potential drug target purine nucleoside phosphorylase from Schistosoma mansoni. Acta Crystallogr. D Biol. Crystallogr.,  2003, 59(Pt 6), 1096-1099.
[http://dx.doi.org/10.1107/S090744490300773X] [PMID: 12777786] 
[43] 
Abdulla, M.H.; Lim, K.C.; Sajid, M.; McKerrow, J.H.; Caffrey, C.R. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med.,  2007, 4(1)e14
[http://dx.doi.org/10.1371/journal.pmed.0040014] [PMID: 17214506] 
[44] 
Xiao, S-H.; Keiser, J.; Chollet, J.; Utzinger, J.; Dong, Y.; Endriss, Y.; Vennerstrom, J.L.; Tanner, M. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob. Agents Chemother.,  2007, 51(4), 1440-1445.
[http://dx.doi.org/10.1128/AAC.01537-06] [PMID: 17283188] 
[45] 
Sayed, A.A.; Simeonov, A.; Thomas, C.J.; Inglese, J.; Austin, C.P.; Williams, D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med.,  2008, 14(4), 407-412.
[http://dx.doi.org/10.1038/nm1737] [PMID: 18345010] 
[46] 
Prast-Nielsen, S.; Huang, H-H.; Williams, D.L. Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases. Biochim. Biophys. Acta,  2011, 1810(12), 1262-1271.
[http://dx.doi.org/10.1016/j.bbagen.2011.06.024] [PMID: 21782895] 
[47] 
Caffrey, C.R.; Williams, D.L.; Todd, M.H.; Nelson, D.L.; Keiser, J.; Utzinger, J. Chemotherapeutic development strategies for schistosomiasis. Antiparasit. Antibact. Drug Discov; From Mol; Targ. Drug Candidates, 2009, pp. 299-321.
[http://dx.doi.org/10.1002/9783527626816.ch16] 
[48] 
Neves, J.K.A.L.; Botelho, S.P.S.; de Melo, C.M.L.; Pereira, V.R.A. de Lima, Mdo.C.; Pitta, Ida.R.; Albuquerque, M.C.; Galdino, S.L. Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni. Parasitol. Res.,  2010, 107(3), 531-538.
[http://dx.doi.org/10.1007/s00436-010-1886-y] [PMID: 20440624] 
[49] 
Magalhães, L.G.; Machado, C.B.; Morais, E.R.; Moreira, E.B.; Soares, C.S.; da Silva, S.H.; Da Silva Filho, A.A.; Rodrigues, V. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol. Res.,  2009, 104(5), 1197-1201.
[http://dx.doi.org/10.1007/s00436-008-1311-y] [PMID: 19096877] 
[50] 
Luz, P.P.; Magalhães, L.G.; Pereira, A.C.; Cunha, W.R.; Rodrigues, V.; Andrade, E. Silva, M.L. Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity. Parasitol. Res.,  2012, 110(2), 593-598.
[http://dx.doi.org/10.1007/s00436-011-2527-9] [PMID: 21739309] 
[51] 
Chan, J.D.; Zarowiecki, M.; Marchant, J.S. Ca2+ channels and praziquantel: a view from the free world. Parasitol. Int.,  2013, 62(6), 619-628.
[http://dx.doi.org/10.1016/j.parint.2012.12.001] [PMID: 23246536] 
[52] 
Abdulla, M.H.; Ruelas, D.S.; Wolff, B.; Snedecor, J.; Lim, K.C.; Xu, F.; Renslo, A.R.; Williams, J.; McKerrow, J.H.; Caffrey, C.R. Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl. Trop. Dis.,  2009, 3(7)e478
[http://dx.doi.org/10.1371/journal.pntd.0000478] [PMID: 19597541] 
[53] 
Keiser, J.; Chollet, J.; Xiao, S-H.; Mei, J-Y.; Jiao, P-Y.; Utzinger, J.; Tanner, M. Mefloquine--an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis.,  2009, 3(1)e350
[http://dx.doi.org/10.1371/journal.pntd.0000350] [PMID: 19125172] 
[54] 
Xiao, S.H.; Mei, J.Y.; Jiao, P.Y. The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol. Res.,  2009, 106(1), 237-246.
[http://dx.doi.org/10.1007/s00436-009-1656-x] [PMID: 19851783] 
[55] 
Dong, Y.; Chollet, J.; Vargas, M.; Mansour, N.R.; Bickle, Q.; Alnouti, Y.; Huang, J.; Keiser, J.; Vennerstrom, J.L. Praziquantel analogs with activity against juvenile Schistosoma mansoni. Bioorg. Med. Chem. Lett.,  2010, 20(8), 2481-2484.
[http://dx.doi.org/10.1016/j.bmcl.2010.03.001] [PMID: 20303754] 
[56] 
Gnanasekar, M.; Salunkhe, A.M.; Mallia, A.K.; He, Y.X.; Kalyanasundaram, R. Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni. Antimicrob. Agents Chemother.,  2009, 53(3), 1054-1060.
[http://dx.doi.org/10.1128/AAC.01222-08] [PMID: 19104008] 
[57] 
Portela, J.; Boissier, J.; Gourbal, B.; Pradines, V.; Collière, V.; Coslédan, F.; Meunier, B.; Robert, A. Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni. PLoS Negl. Trop. Dis.,  2012, 6(2)e1474
[http://dx.doi.org/10.1371/journal.pntd.0001474] [PMID: 22348155] 
[58] 
Keiser, J.; Vargas, M.; Vennerstrom, J.L. Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice. J. Antimicrob. Chemother.,  2010, 65(9), 1991-1995.
[http://dx.doi.org/10.1093/jac/dkq233] [PMID: 20576641] 
[59] 
El Ridi, R.; Aboueldahab, M.; Tallima, H.; Salah, M.; Mahana, N.; Fawzi, S.; Mohamed, S.H.; Fahmy, O.M. In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium. Antimicrob. Agents Chemother.,  2010, 54(8), 3383-3389.
[http://dx.doi.org/10.1128/AAC.00173-10] [PMID: 20479203] 
[60] 
El Ridi, R.; Tallima, H.; Salah, M.; Aboueldahab, M.; Fahmy, O.M.; Al-Halbosiy, M.F.; Mahmoud, S.S. Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schistosoma mansoni or Schistosoma haematobium. Int. J. Antimicrob. Agents,  2012, 39(3), 232-239.
[http://dx.doi.org/10.1016/j.ijantimicag.2011.08.019] [PMID: 22240411] 
[61] 
Eissa, M.M.; El-Azzouni, M.Z.; Amer, E.I.; Baddour, N.M. Miltefosine, a promising novel agent for schistosomiasis mansoni. Int. J. Parasitol.,  2011, 41(2), 235-242.
[http://dx.doi.org/10.1016/j.ijpara.2010.09.010] [PMID: 21055404] 
[62] 
Guglielmo, S.; Cortese, D.; Vottero, F.; Rolando, B.; Kommer, V.P.; Williams, D.L.; Fruttero, R.; Gasco, A. New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni. Eur. J. Med. Chem.,  2014, 84, 135-145.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.007] [PMID: 25016371] 
[63] 
Kapadia, G.J.; Soares, I.A.O.; Rao, G.S.; Badoco, F.R.; Furtado, R.A.; Correa, M.B.; Tavares, D.C.; Cunha, W.R.; Magalhães, L.G. Antiparasitic activity of menadione (vitamin K3) against Schistosoma mansoni in BABL/c mice. Acta Trop.,  2017, 167, 163-173.
[http://dx.doi.org/10.1016/j.actatropica.2016.12.001] [PMID: 28017859] 
[64] 
Singh, R.; Yadav, B.S.; Singh, S.; Pandey, P.N.; Mani, A. In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidates. Springerplus,  2016, 5(1), 286.
[http://dx.doi.org/10.1186/s40064-016-1891-4] [PMID: 27066323] 
[65] 
Cheng, G.; Jin, Y. MicroRNAs: potentially important regulators for schistosome development and therapeutic targets against schistosomiasis. Parasitology,  2012, 139(5), 669-679.
[http://dx.doi.org/10.1017/S0031182011001855] [PMID: 22309492] 
[66] 
Verjovski-Almeida, S.; DeMarco, R.; Martins, E.A.; Guimarães, P.E.; Ojopi, E.P.; Paquola, A.C.; Piazza, J.P.; Nishiyama, M.Y., Jr; Kitajima, J.P.; Adamson, R.E.; Ashton, P.D.; Bonaldo, M.F.; Coulson, P.S.; Dillon, G.P.; Farias, L.P.; Gregorio, S.P.; Ho, P.L.; Leite, R.A.; Malaquias, L.C.; Marques, R.C.; Miyasato, P.A.; Nascimento, A.L.; Ohlweiler, F.P.; Reis, E.M.; Ribeiro, M.A.; Sá, R.G.; Stukart, G.C.; Soares, M.B.; Gargioni, C.; Kawano, T.; Rodrigues, V.; Madeira, A.M.; Wilson, R.A.; Menck, C.F.; Setubal, J.C.; Leite, L.C.; Dias-Neto, E. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat. Genet.,  2003, 35(2), 148-157.
[http://dx.doi.org/10.1038/ng1237] [PMID: 12973350] 
[67] 
Vicogne, J.; Dissous, C. Schistosoma mansoni receptor tyrosine kinases: towards new therapeutic targets J. Soc. Biol.,  2003, 197(4), 367-373.
[http://dx.doi.org/10.1051/jbio/2003197040367] [PMID: 15005518] 
[68] 
Dissous, C.; Vanderstraete, M.; Beckmann, S.; Gouignard, N.; Leutner, S.; Buro, C.; Grevelding, C.G. Receptor tyrosine kinase signaling and drug targeting in schistosomes; Protein Phosphorylation Parasites Novel Targets Antiparasit; Interv, 2014, pp. 337-356.
[69] 
Morel, M.; Vanderstraete, M.; Cailliau, K.; Lescuyer, A.; Lancelot, J.; Dissous, C. Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis. Int. J. Parasitol. Drugs Drug Resist.,  2014, 4(3), 256-266.
[http://dx.doi.org/10.1016/j.ijpddr.2014.09.004] [PMID: 25516836] 
[70] 
Pramod, A.B.; Foster, J.; Carvelli, L.; Henry, L.K. SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol. Aspects Med.,  2013, 34(2-3), 197-219.
[http://dx.doi.org/10.1016/j.mam.2012.07.002] [PMID: 23506866] 
[71] 
Zamanian, M.; Kimber, M.J.; McVeigh, P.; Carlson, S.A.; Maule, A.G.; Day, T.A. The repertoire of G protein-coupled receptors in the human parasite Schistosoma mansoni and the model organism Schmidtea mediterranea. BMC Genomics,  2011, 12(1), 596.
[http://dx.doi.org/10.1186/1471-2164-12-596] [PMID: 22145649] 
[72] 
Campos, T.D.; Young, N.D.; Korhonen, P.K.; Hall, R.S.; Mangiola, S.; Lonie, A.; Gasser, R.B. Identification of G protein-coupled receptors in Schistosoma haematobium and S. mansoni by comparative genomics. Parasit. Vectors,  2014, 7(1), 242.
[http://dx.doi.org/10.1186/1756-3305-7-242] [PMID: 24884876] 
[73] 
Crowther, G.J.; Shanmugam, D.; Carmona, S.J.; Doyle, M.A.; Hertz-Fowler, C.; Berriman, M.; Nwaka, S.; Ralph, S.A.; Roos, D.S.; Van Voorhis, W.C.; Agüero, F. Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl. Trop. Dis.,  2010, 4(8)e804
[http://dx.doi.org/10.1371/journal.pntd.0000804] [PMID: 20808766] 
[74] 
Zerlotini, A.; Heiges, M.; Wang, H.; Moraes, R.L.; Dominitini, A.J.; Ruiz, J.C.; Kissinger, J.C.; Oliveira, G.; Schisto, D.B. SchistoDB: a Schistosoma mansoni genome resource. Nucleic Acids Res.,  2009, 37(Database issue)(Suppl. 1), D579-D582.
[http://dx.doi.org/10.1093/nar/gkn681] [PMID: 18842636] 
[75] 
Wieland Brown, L.C.; Acker, M.G.; Clardy, J.; Walsh, C.T.; Fischbach, M.A. Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin. Proc. Natl. Acad. Sci. USA,  2009, 106(8), 2549-2553.
[http://dx.doi.org/10.1073/pnas.0900008106] [PMID: 19196969] 
[76] 
Van Voorhis, W.C.; Hol, W.G.; Myler, P.J.; Stewart, L.J. The role of medical structural genomics in discovering new drugs for infectious diseases. PLOS Comput. Biol.,  2009, 5(10)e1000530
[http://dx.doi.org/10.1371/journal.pcbi.1000530] [PMID: 19855826] 
[77] 
Bergquist, R.; Al-Sherbiny, M.; Barakat, R.; Olds, R. Blueprint for schistosomiasis vaccine development. Acta Trop.,  2002, 82(2), 183-192.
[http://dx.doi.org/10.1016/S0001-706X(02)00048-7] [PMID: 12020891] 
[78] 
Padalino, G.; Ferla, S.; Brancale, A.; Chalmers, I.W.; Hoffmann, K.F. Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni. Int. J. Parasitol. Drugs Drug Resist.,  2018, 8(3), 559-570.
[http://dx.doi.org/10.1016/j.ijpddr.2018.10.005] [PMID: 30455056] 
[79] 
Cowan, N.; Keiser, J. Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni. Parasit. Vectors,  2015, 8(1), 417.
[http://dx.doi.org/10.1186/s13071-015-1023-y] [PMID: 26265386] 
[80] 
Panic, G.; Vargas, M.; Scandale, I.; Keiser, J. Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni. PLoS Negl. Trop. Dis.,  2015, 9(7)e0003962
[http://dx.doi.org/10.1371/journal.pntd.0003962] [PMID: 26230921] 
[81] 
Giuliani, S.; Silva, A.C.; Borba, J.V.V.B.; Ramos, P.I.P.; Paveley, R.A.; Muratov, E.N.; Andrade, C.H.; Furnham, N. Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents. PLOS Comput. Biol.,  2018, 14(10)e1006515
[http://dx.doi.org/10.1371/journal.pcbi.1006515] [PMID: 30346968] 
[82] 
Gelmedin, V.; Dissous, C.; Grevelding, C.G. Re-positioning protein-kinase inhibitors against schistosomiasis. Future Med. Chem.,  2015, 7(6), 737-752.
[http://dx.doi.org/10.4155/fmc.15.31] [PMID: 25996067] 
[83] 
Neves, B.J.; Braga, R.C.; Bezerra, J.C.; Cravo, P.V.; Andrade, C.H. In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni. PLoS Negl. Trop. Dis.,  2015, 9(1)e3435
[http://dx.doi.org/10.1371/journal.pntd.0003435] [PMID: 25569258] 
[84] 
Eweas, A.F.; Allam, G. Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target. Mol. Biochem. Parasitol.,  2018, 225, 94-102.
[http://dx.doi.org/10.1016/j.molbiopara.2018.09.004] [PMID: 30291946] 
[85] 
Melo-Filho, C.C.; Dantas, R.F.; Braga, R.C.; Neves, B.J.; Senger, M.R.; Valente, W.C.; Rezende-Neto, J.M.; Chaves, W.T.; Muratov, E.N.; Paveley, R.A.; Furnham, N.; Kamentsky, L.; Carpenter, A.E.; Silva-Junior, F.P.; Andrade, C.H. QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni. J. Chem. Inf. Model.,  2016, 56(7), 1357-1372.
[http://dx.doi.org/10.1021/acs.jcim.6b00055] [PMID: 27253773] 
[86] 
Pearce, E.J. Progress towards a vaccine for schistosomiasis. Acta Trop.,  2003, 86(2-3), 309-313.
[http://dx.doi.org/10.1016/S0001-706X(03)00062-7] [PMID: 12745147] 
[87] 
Dalton, J.P.; Brindley, P.J.; Knox, D.P.; Brady, C.P.; Hotez, P.J.; Donnelly, S.; O’Neill, S.M.; Mulcahy, G.; Loukas, A. Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. Int. J. Parasitol.,  2003, 33(5-6), 621-640.
[http://dx.doi.org/10.1016/S0020-7519(03)00057-2] [PMID: 12782060] 
[88] 
Capron, A.; Capron, M.; Riveau, G. Vaccine development against schistosomiasis from concepts to clinical trials. Br. Med. Bull.,  2002, 62(1), 139-148.
[http://dx.doi.org/10.1093/bmb/62.1.139] [PMID: 12176856] 
[89] 
Al-Sherbiny, M.; Osman, A.; Barakat, R.; El Morshedy, H.; Bergquist, R.; Olds, R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop.,  2003, 88(2), 117-130.
[http://dx.doi.org/10.1016/S0001-706X(03)00195-5] [PMID: 14516923] 
[90] 
Zinsser, V.L.; Farnell, E.; Dunne, D.W.; Timson, D.J. Triose phosphate isomerase from the blood fluke Schistosoma mansoni: biochemical characterisation of a potential drug and vaccine target. FEBS Lett.,  2013, 587(21), 3422-3427.
[http://dx.doi.org/10.1016/j.febslet.2013.09.022] [PMID: 24070897] 
[91] 
Maule, A.G.; Marks, N.J. Parasitic flatworms: molecular biology, biochemistry, immunology and physiology; CABI, 2006. 
[92] 
Brito, C.F.; Oliveira, G.C.; Oliveira, S.C.; Street, M.; Riengrojpitak, S.; Wilson, R.A.; Simpson, A.J.; Correa-Oliveira, R. Sm14 gene expression in different stages of the Schistosoma mansoni life cycle and immunolocalization of the Sm14 protein within the adult worm. Braz. J. Med. Biol. Res.,  2002, 35(3), 377-381.
[http://dx.doi.org/10.1590/S0100-879X2002000300014] [PMID: 11887217] 
[93] 
Tendler, M.; Simpson, A.J. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Acta Trop.,  2008, 108(2-3), 263-266.
[http://dx.doi.org/10.1016/j.actatropica.2008.09.002] [PMID: 18834847] 
[94] 
McManus, D.P.; Loukas, A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev.,  2008, 21(1), 225-242.
[http://dx.doi.org/10.1128/CMR.00046-07] [PMID: 18202444] 
[95] 
Ali, S.A.; Hamed, M.A. Schistosomiasis Vaccine: Research to Development. Int. J. Pharm. Clin. Res.,  2014, 6(2), 107-120.
[96] 
Bethony, J.M.; Diemert, D.J.; Oliveira, S.C.; Loukas, A. Can schistosomiasis really be consigned to history without a vaccine? Vaccine,  2008, 26(27-28), 3373-3376.
[http://dx.doi.org/10.1016/j.vaccine.2008.04.045] [PMID: 18513839] 
[97] 
Mo, A.X.; Agosti, J.M.; Walson, J.L.; Hall, B.F.; Gordon, L. Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals. Am. J. Trop. Med. Hyg.,  2014, 90(1), 54-60.
[http://dx.doi.org/10.4269/ajtmh.13-0467] [PMID: 24402703] 
[98] 
Chaudhury, A. Journal of Clinical and Biomedical Sciences. J Clin. Biomed. Sci.,  2014, 4(1), 216-221.
[99] 
DeMarco, R.; Verjovski-Almeida, S. Schistosomes--proteomics studies for potential novel vaccines and drug targets. Drug Discov. Today,  2009, 14(9-10), 472-478.
[http://dx.doi.org/10.1016/j.drudis.2009.01.011] [PMID: 19429506] 
[100] 
Castro-Borges, W.; Dowle, A.; Curwen, R.S.; Thomas-Oates, J.; Wilson, R.A. Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates. PLoS Negl. Trop. Dis.,  2011, 5(3)e993
[http://dx.doi.org/10.1371/journal.pntd.0000993] [PMID: 21468311] 
[101] 
Driguez, P.; Doolan, D.L.; Loukas, A.; Felgner, P.L.; McManus, D.P. Schistosomiasis vaccine discovery using immunomics. Parasit. Vectors,  2010, 3(1), 4.
[http://dx.doi.org/10.1186/1756-3305-3-4] [PMID: 20181031] 
[102] 
Chen, J-H.; Zhang, T.; Ju, C.; Xu, B.; Lu, Y.; Mo, X-J.; Chen, S-B.; Fan, Y-T.; Hu, W.; Zhou, X-N. An integrated immunoproteomics and bioinformatics approach for the analysis of Schistosoma japonicum tegument proteins. J. Proteomics,  2014, 98, 289-299.
[http://dx.doi.org/10.1016/j.jprot.2014.01.010] [PMID: 24448400] 
[103] 
McWilliam, H.E.; Driguez, P.; Piedrafita, D.; McManus, D.P.; Meeusen, E.N. Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach. Parasit. Vectors,  2014, 7(1), 290.
[http://dx.doi.org/10.1186/1756-3305-7-290] [PMID: 24964958] 
[104] 
Gobert, G.N.; Moertel, L.; Brindley, P.J.; McManus, D.P. Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics,  2009, 10(1), 128.
[http://dx.doi.org/10.1186/1471-2164-10-128] [PMID: 19320991] 
[105] 
Ewaisha, R.E.; Bahey-El-Din, M.; Mossallam, S.F.; Amer, E.I.; Aboushleib, H.M.; Khalil, A.M. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection. Exp. Parasitol.,  2014, 145, 51-60.
[http://dx.doi.org/10.1016/j.exppara.2014.07.010] [PMID: 25092439] 
[106] 
Diniz, P.P.; Nakajima, E.; Miyasato, P.A.; Nakano, E.; de Oliveira Rocha, M.; Martins, E.A.L. Two SmDLC antigens as potential vaccines against schistosomiasis. Acta Trop.,  2014, 140, 193-201.
[http://dx.doi.org/10.1016/j.actatropica.2014.09.006] [PMID: 25240208] 
[107] 
Thomas, P.G.; Harn, D.A., Jr Immune biasing by helminth glycans. Cell. Microbiol.,  2004, 6(1), 13-22.
[http://dx.doi.org/10.1046/j.1462-5822.2003.00337.x] [PMID: 14678327] 
[108] 
Hokke, C.H.; Yazdanbakhsh, M. Schistosome glycans and innate immunity. Parasite Immunol.,  2005, 27(7-8), 257-264.
[http://dx.doi.org/10.1111/j.1365-3024.2005.00781.x] [PMID: 16138846] 
[109] 
Hahn, U.K.; Bender, R.C.; Bayne, C.J. Production of reactive oxygen species by hemocytes of Biomphalaria glabrata: carbohydrate-specific stimulation. Dev. Comp. Immunol.,  2000, 24(6-7), 531-541.
[http://dx.doi.org/10.1016/S0145-305X(00)00017-3] [PMID: 10831788] 
[110] 
Castillo, M.G.; Wu, X-J.; Dinguirard, N.; Nyame, A.K.; Cummings, R.D.; Yoshino, T.P. Surface membrane proteins of Biomphalaria glabrata embryonic cells bind fucosyl determinants on the tegumental surface of Schistosoma mansoni primary sporocysts. J. Parasitol.,  2007, 93(4), 832-840.
[http://dx.doi.org/10.1645/GE-954R.1] [PMID: 17918362] 
[111] 
Yoshino, T.P.; Wu, X-J.; Gonzalez, L.A.; Hokke, C.H. Circulating Biomphalaria glabrata hemocyte subpopulations possess shared schistosome glycans and receptors capable of binding larval glycoconjugates. Exp. Parasitol.,  2013, 133(1), 28-36.
[http://dx.doi.org/10.1016/j.exppara.2012.10.002] [PMID: 23085445] 
[112] 
Mickum, M.L.; Prasanphanich, N.S.; Heimburg-Molinaro, J.; Leon, K.E.; Cummings, R.D. Deciphering the glycogenome of schistosomes. Front. Genet.,  2014, 5, 262.
[http://dx.doi.org/10.3389/fgene.2014.00262] [PMID: 25147556] 
[113] 
Peterson, N.A.; Hokke, C.H.; Deelder, A.M.; Yoshino, T.P. Glycotope analysis in miracidia and primary sporocysts of Schistosoma mansoni: differential expression during the miracidium-to-sporocyst transformation. Int. J. Parasitol.,  2009, 39(12), 1331-1344.
[http://dx.doi.org/10.1016/j.ijpara.2009.06.002] [PMID: 19545571] 
[114] 
Peterson, N.A.; Anderson, T.K.; Yoshino, T.P. In silico analysis of the fucosylation-associated genome of the human blood fluke Schistosoma mansoni: cloning and characterization of the fucosyltransferase multigene family. PLoS One,  2013, 8(5)e63299
[http://dx.doi.org/10.1371/journal.pone.0063299] [PMID: 23696810] 
[115] 
Garcia, L.; Shimizu, R.; Paltridge, G.; Murray, P.; Baron, E.; Jorgensen, J.; Landry, M.; Pfaller, M. Algorithms for detection and identification of parasites. In: Manual of clinical microbiology, Ed. 9; , 2006; 2, pp. 2020-2039.
[116] 
Lamberton, P.H.; Kabatereine, N.B.; Oguttu, D.W.; Fenwick, A.; Webster, J.P. Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment. PLoS Negl. Trop. Dis.,  2014, 8(9)e3139
[http://dx.doi.org/10.1371/journal.pntd.0003139] [PMID: 25211217] 
[117] 
Jurberg, A.D.; Oliveira, A.A.; Lenzi, H.L.; Coelho, P.M.Z. A new miracidia hatching device for diagnosing schistosomiasis. Mem. Inst. Oswaldo Cruz,  2008, 103(1), 112-114.
[http://dx.doi.org/10.1590/S0074-02762008005000005] [PMID: 18345461] 
[118] 
Cringoli, G. FLOTAC, a novel apparatus for a multivalent faecal egg count technique. Parassitologia,  2006, 48(3), 381-384.
[PMID: 17176947] 
[119] 
Ibironke, O.A.; Phillips, A.E.; Garba, A.; Lamine, S.M.; Shiff, C. Diagnosis of Schistosoma haematobium by detection of specific DNA fragments from filtered urine samples. Am. J. Trop. Med. Hyg.,  2011, 84(6), 998-1001.
[http://dx.doi.org/10.4269/ajtmh.2011.10-0691] [PMID: 21633040] 
[120] 
Zhao, G-H.; Li, J.; Blair, D.; Li, X-Y.; Elsheikha, H.M.; Lin, R-Q.; Zou, F-C.; Zhu, X-Q. Biotechnological advances in the diagnosis, species differentiation and phylogenetic analysis of Schistosoma spp. Biotechnol. Adv.,  2012, 30(6), 1381-1389.
[http://dx.doi.org/10.1016/j.biotechadv.2012.02.008] [PMID: 22366555] 
[121] 
Zhou, Y.B.; Zheng, H.M.; Jiang, Q.W. A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control. Parasit. Vectors,  2011, 4, 194.
[http://dx.doi.org/10.1186/1756-3305-4-194] [PMID: 21981948] 
[122] 
Zhou, X-H.; Wu, J-Y.; Huang, X-Q.; Kunnon, S.P.; Zhu, X-Q.; Chen, X-G. Identification and characterization of Schistosoma japonicum Sjp40, a potential antigen candidate for the early diagnosis of schistosomiasis. Diagn. Microbiol. Infect. Dis.,  2010, 67(4), 337-345.
[http://dx.doi.org/10.1016/j.diagmicrobio.2010.03.003] [PMID: 20638601] 
[123] 
Lu, Y.; Xu, B.; Ju, C.; Mo, X.; Chen, S.; Feng, Z.; Wang, X.; Hu, W. Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients. Parasit. Vectors,  2012, 5, 115.
[http://dx.doi.org/10.1186/1756-3305-5-115] [PMID: 22686541] 
[124] 
Guo, J.J.; Zheng, H.J.; Xu, J.; Zhu, X.Q.; Wang, S.Y.; Xia, C.M. Sensitive and specific target sequences selected from retrotransposons of Schistosoma japonicum for the diagnosis of schistosomiasis. PLoS Negl. Trop. Dis.,  2012, 6(3)e1579
[http://dx.doi.org/10.1371/journal.pntd.0001579] [PMID: 22479661] 
[125] 
Doenhoff, M.J.; Chiodini, P.L.; Hamilton, J.V. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol.,  2004, 20(1), 35-39.
[http://dx.doi.org/10.1016/j.pt.2003.10.019] [PMID: 14700588] 
[126] 
Balog, C.I.; Meissner, A.; Göraler, S.; Bladergroen, M.R.; Vennervald, B.J.; Mayboroda, O.A.; Deelder, A.M. Metabonomic investigation of human Schistosoma mansoni infection. Mol. Biosyst.,  2011, 7(5), 1473-1480.
[http://dx.doi.org/10.1039/c0mb00262c] [PMID: 21336380] 
[127] 
Goto, Y.; Carter, D.; Guderian, J.; Inoue, N.; Kawazu, S.; Reed, S.G. Upregulated expression of B-cell antigen family tandem repeat proteins by Leishmania amastigotes. Infect. Immun.,  2010, 78(5), 2138-2145.
[http://dx.doi.org/10.1128/IAI.01102-09] [PMID: 20160013] 
[128] 
Angeles, J.M.; Goto, Y.; Kirinoki, M.; Leonardo, L.; Tongol-Rivera, P.; Villacorte, E.; Inoue, N.; Chigusa, Y.; Kawazu, S. Human antibody response to thioredoxin peroxidase-1 and tandem repeat proteins as immunodiagnostic antigen candidates for Schistosoma japonicum infection. Am. J. Trop. Med. Hyg.,  2011, 85(4), 674-679.
[http://dx.doi.org/10.4269/ajtmh.2011.11-0245] [PMID: 21976571] 
[129] 
Xing, W.; Yu, X.; Feng, J.; Sun, K.; Fu, W.; Wang, Y.; Zou, M.; Xia, W.; Luo, Z.; He, H.; Li, Y.; Xu, D. Field evaluation of a recombinase polymerase amplification assay for the diagnosis of Schistosoma japonicum infection in Hunan province of China. BMC Infect. Dis.,  2017, 17(1), 164.
[http://dx.doi.org/10.1186/s12879-017-2182-6] [PMID: 28222680] 
[130] 
Santos, G.S.; Andrade, C.A.; Bruscky, I.S.; Wanderley, L.B.; Melo, F.L.; Oliveira, M.D. Impedimetric nanostructured genosensor for detection of schistosomiasis in cerebrospinal fluid and serum samples. J. Pharm. Biomed. Anal.,  2017, 137, 163-169.
[http://dx.doi.org/10.1016/j.jpba.2017.01.031] [PMID: 28131054] 
[131] 
Smith, H.; Doenhoff, M.; Aitken, C.; Bailey, W.; Ji, M.; Dawson, E.; Gilis, H.; Spence, G.; Alexander, C.; van Gool, T. Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections.,  2012, 6(9), 1-14.
[http://dx.doi.org/10.1371/journal.pntd.0001815] 
[132] 
Coulibaly, J.T.; N’Goran, E.K.; Utzinger, J.; Doenhoff, M.J.; Dawson, E.M. A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-Schistosoma haematobium antibodies. Parasit. Vectors,  2013, 6, 29.
[http://dx.doi.org/10.1186/1756-3305-6-29] [PMID: 23360734] 
[133] 
Ochodo, E.A.; Gopalakrishna, G.; Spek, B.; Reitsma, J.B.; van Lieshout, L.; Polman, K.; Lamberton, P.; Bossuyt, P.M.; Leeflang, M.M. Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas. The Cochrane Database of Systematic Reviews, 2015.
[http://dx.doi.org/10.1002/14651858.CD009579.pub2] 
[134] 
Wen, Z.; Wang, S.; Wu, Z.; Shen, G. A novel liquid-phase piezoelectric immunosensor for detecting Schistosoma japonicum circulating antigen. Parasitol. Int.,  2011, 60(3), 301-306.
[http://dx.doi.org/10.1016/j.parint.2011.05.001] [PMID: 21609782] 
[135] 
van Dam, G.J.; Wichers, J.H.; Ferreira, T.M.; Ghati, D.; van Amerongen, A.; Deelder, A.M. Diagnosis of schistosomiasis by reagent strip test for detection of circulating cathodic antigen. J. Clin. Microbiol.,  2004, 42(12), 5458-5461.
[http://dx.doi.org/10.1128/JCM.42.12.5458-5461.2004] [PMID: 15583265] 
[136] 
Lier, T.; Simonsen, G.S.; Haaheim, H.; Hjelmevoll, S.O.; Vennervald, B.J.; Johansen, M.V. Novel real-time PCr for detection of Schistosoma japonicum in stool. Southeast Asian J. Trop. Med. Public Health,  2006, 37(2), 257-264.
[PMID: 17124983] 
[137] 
Gomes, L.I.; Dos Santos Marques, L.H.; Enk, M.J.; de Oliveira, M.C.; Coelho, P.M.Z.; Rabello, A. Development and evaluation of a sensitive PCR-ELISA system for detection of schistosoma infection in feces. PLoS Negl. Trop. Dis.,  2010, 4(4)e664
[http://dx.doi.org/10.1371/journal.pntd.0000664] [PMID: 20421918] 
[138] 
Xu, J.; Rong, R.; Zhang, H.Q.; Shi, C.J.; Zhu, X.Q.; Xia, C.M. Sensitive and rapid detection of Schistosoma japonicum DNA by loop-mediated isothermal amplification (LAMP). Int. J. Parasitol.,  2010, 40(3), 327-331.
[http://dx.doi.org/10.1016/j.ijpara.2009.08.010] [PMID: 19735662] 
[139] 
Cortez, M.A.; Bueso-Ramos, C.; Ferdin, J.; Lopez-Berestein, G.; Sood, A.K.; Calin, G.A. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol.,  2011, 8(8), 467-477.
[http://dx.doi.org/10.1038/nrclinonc.2011.76] [PMID: 21647195] 
[140] 
Manzano-Román, R.; Siles-Lucas, M. MicroRNAs in parasitic diseases: potential for diagnosis and targeting. Mol. Biochem. Parasitol.,  2012, 186(2), 81-86.
[http://dx.doi.org/10.1016/j.molbiopara.2012.10.001] [PMID: 23069113] 
[141] 
Wang, S.; Hu, W. Development of “-omics” research in Schistosoma spp. and-omics-based new diagnostic tools for schistosomiasis. Front. Microbiol.,  2014, 5, 1-11.
[http://dx.doi.org/10.3389/fmicb.2014.00313] 
Cite As
Infectious Disorders - Drug Targets

Current Progress on the Genomics of Schistosomiasis for Drug Discovery and Diagnostics

Abstract
